샘플 요청 목록

 카트 문의
시장보고서
상품코드
1793710

세계의 제약 자동화 시장

Pharmaceutical Automation
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 371 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

제약 자동화 세계 시장은 2030년까지 204억 달러에 달할 전망

2024년에 120억 달러로 추정되는 제약 자동화 세계 시장은 2024년부터 2030년까지 CAGR 9.3%로 성장하여 2030년에는 204억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 솔루션 구성요소는 CAGR 8.2%를 기록하며 분석 기간 종료시에는 129억 달러에 달할 것으로 예측됩니다. 서비스 구성요소 분야의 성장률은 분석 기간 동안 CAGR 11.3%로 추정됩니다.

미국 시장은 33억 달러, 중국은 CAGR 12.6%로 성장할 것으로 예측

미국의 제약 자동화 시장은 2024년에 33억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 41억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 12.6%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 6.7%와 8.1%로 예측됩니다. 유럽에서는 독일이 CAGR 약 7.3%로 성장할 것으로 예측됩니다.

세계의 제약 자동화 시장 - 주요 동향과 촉진요인 정리

의약품 제조에서 자동화가 기본이 되고 있는 이유는 무엇일까?

제약 자동화는 제어 시스템, 로봇 공학, 디지털 도구를 사용하여 제조, 포장, 검사, 자재 취급 공정을 최소한의 인력 개입으로 수행합니다. 제품 일관성 향상, 오염 위험 감소, 규제 준수 강화. 의약품이 점점 더 복잡해지고 생산량이 증가함에 따라 자동화는 효율성과 추적성을 보장하는 데 있어 핵심적인 역할을 하고 있습니다.

자동화는 제형화, 무균 충전, 검사, 라벨링, 창고 보관 등 업스트림에서 다운스트림 공정에 이르기까지 광범위하게 이루어집니다. 자동화 시스템은 배치의 정확성, 실시간 모니터링, 규제 감사를 위한 문서화를 보장합니다. 로봇공학은 안전과 정확성이 중요한 무균 환경이나 고농도 격리 구역에서 수작업을 줄이는 데 특히 유용합니다.

기술은 어떻게 발전하고 어디에 적용되고 있는가?

최신 제약 자동화는 프로그래머블 로직 컨트롤러(PLC), 분산 제어 시스템(DCS), 제조 실행 시스템(MES)의 통합입니다. 이러한 도구는 공정 일관성, 배치 모니터링, 편차 제어를 지원합니다. 포장, 바이알 충전, 주사기 취급, 완제품의 육안 검사에 로봇이 사용되고 있습니다.

프로세스 분석 기술(PAT)과 디지털 트윈의 채택으로 실시간 프로세스 모니터링과 예측 제어가 진행되고 있습니다. 자동운반차(AGV)는 창고 물류에 도입되고, 클린룸용 로봇은 무균 제조라인이나 위험한 제조라인에 도입되고 있습니다. 인공지능과 머신러닝은 예지보전, 수율 최적화, 품질 리스크 평가에도 적용되고 있습니다.

자동화가 가장 활발하게 도입되고 있는 곳은 어디이며, 어떤 제품 분야가 가장 활발하게 도입되고 있는가?

대규모 생물학적 제제, 백신 제조, 무균 주사제 제조 시설은 공정의 민감도가 높고 일관된 오염 제어가 필요하기 때문에 자동화 도입에 앞장서고 있습니다. 경구용 고형제 생산 라인도 과립화, 혼합, 정제 코팅을 위해 자동화되어 있습니다. 북미, 유럽, 일본의 고처리량 시설은 운영 비용을 절감하고 생산량 예측 가능성을 높이기 위해 자동화를 도입하고 있습니다.

신흥국 시장에서는 제약회사들이 포장 라인, 창고 작업, 품질 관리 유닛을 자동화하기 시작했습니다. CDMO와 제네릭 제약사들은 경쟁력을 유지하고 국제 표준을 준수하기 위해 자동화에 투자하고 있습니다. 자동화는 또한 맞춤형 의료 및 틈새 생물학적 제제의 소량 생산을 지원하는 데에도 활용되고 있습니다.

제약 자동화 시장의 성장은 몇 가지 요인에 의해 이루어집니다.

제약 자동화 시장의 성장은 제약 제조의 복잡성, 무공해 생산의 필요성, 확장 가능한 데이터 기반 공정 제어 시스템의 채택에 의해 이루어지고 있습니다. 생물학적 제제 제조의 확대, 세포 및 유전자 치료 플랫폼의 부상, 세계 품질 요구 사항의 강화로 인해 모든 생산 단계의 자동화가 촉진되고 있습니다.

MES, 무균 구역에서의 로봇 공학, 실시간 품질 검사 도구의 사용 확대로 제조업체는 추적성을 개선하고 오류율을 줄일 수 있습니다. 연속 생산, 자동 외관 검사, 고속 충전 마감 라인에 대한 투자도 시장을 확대하고 있습니다. 데이터 무결성 및 프로세스 검증에 대한 규제 당국의 기대가 높아지면서 제약 자동화는 미래 대응 가능한 생산 인프라에 필수적인 요소로 자리 잡고 있습니다.

부문

구성요소(솔루션 구성요소, 서비스 구성요소), 자동화 모드(반자동 시스템, 전자동 시스템), 최종사용자(의약품 최종사용자, 바이오테크놀러지 최종사용자)

조사 대상 기업 사례

  • ABB Ltd
  • ACG Group
  • Aerotech Inc.
  • ATS Corporation
  • Bausch+Strobel Maschinenfabrik
  • Bosch Rexroth AG
  • Brooks Automation(now Azenta)
  • Festo AG & Co. KG
  • Honeywell International Inc.
  • IMA Group
  • Korber Pharma
  • Marchesini Group
  • Mitsubishi Electric Corporation
  • Omron Corporation
  • Rockwell Automation, Inc.
  • Romaco Group
  • Schneider Electric
  • Siemens AG
  • Systec & Services GmbH
  • Yaskawa Electric Corporation

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계 고유의 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.26

Global Pharmaceutical Automation Market to Reach US$20.4 Billion by 2030

The global market for Pharmaceutical Automation estimated at US$12.0 Billion in the year 2024, is expected to reach US$20.4 Billion by 2030, growing at a CAGR of 9.3% over the analysis period 2024-2030. Solutions Component, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$12.9 Billion by the end of the analysis period. Growth in the Services Component segment is estimated at 11.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 12.6% CAGR

The Pharmaceutical Automation market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2030 trailing a CAGR of 12.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Global Pharmaceutical Automation Market - Key Trends & Drivers Summarized

Why Is Automation Becoming Fundamental in Pharmaceutical Manufacturing?

Pharmaceutical automation involves the use of control systems, robotics, and digital tools to perform manufacturing, packaging, inspection, and material handling processes with minimal human intervention. It improves product consistency, reduces contamination risks, and enhances regulatory compliance. As pharmaceutical products become more complex and production volumes grow, automation is playing a central role in ensuring efficiency and traceability.

Automation spans upstream and downstream processes, including formulation, aseptic filling, inspection, labeling, and warehousing. Automated systems ensure batch accuracy, real-time monitoring, and documentation for regulatory audits. Robotics are particularly valuable in reducing manual handling in sterile environments and high-containment zones, where safety and precision are critical.

How Are Technologies Advancing and Where Are They Being Applied?

Modern pharmaceutical automation is integrating programmable logic controllers (PLCs), distributed control systems (DCS), and manufacturing execution systems (MES). These tools support process consistency, batch monitoring, and deviation control. Robotics are increasingly used for packaging, vial filling, syringe handling, and visual inspection of finished products.

Adoption of process analytical technology (PAT) and digital twins is advancing real-time process monitoring and predictive control. Automated guided vehicles (AGVs) are being deployed in warehouse logistics, while cleanroom-compatible robots are entering aseptic and hazardous production lines. Artificial intelligence and machine learning are also being applied to predictive maintenance, yield optimization, and quality risk assessment.

Where Is Automation Being Deployed Most Aggressively and in Which Product Areas?

Large-scale biologics, vaccine production, and sterile injectable facilities are leading in automation adoption due to high process sensitivity and the need for consistent contamination control. Oral solid dosage manufacturing lines are also automated for granulation, blending, and tablet coating. High-throughput facilities in North America, Europe, and Japan are incorporating automation to reduce operational costs and increase output predictability.

In developing markets, pharmaceutical companies are beginning to automate packaging lines, warehouse operations, and quality control units. CDMOs and generics manufacturers are investing in automation to maintain competitiveness and ensure compliance with international standards. Automation is also being used to support small-batch production in personalized medicine and niche biologics.

Growth in the Pharmaceutical Automation market is driven by several factors…

Growth in the pharmaceutical automation market is driven by increasing complexity of drug manufacturing, need for contamination-free production, and adoption of scalable, data-driven process control systems. Expansion of biologics manufacturing, rise of cell and gene therapy platforms, and stricter global quality requirements are encouraging automation across all production phases.

Wider use of MES, robotics in aseptic zones, and real-time quality inspection tools is enabling manufacturers to improve traceability and reduce error rates. Investments in continuous manufacturing, automated visual inspection, and high-speed fill-finish lines are also expanding the market. As regulatory expectations for data integrity and process validation grow, pharmaceutical automation is becoming integral to future-ready production infrastructure.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical Automation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Solutions Component, Services Component); Automation Mode (Semi-Automatic Systems, Fully Automatic Systems); End-Use (Pharmaceuticals End-Use, Biotech End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • ABB Ltd
  • ACG Group
  • Aerotech Inc.
  • ATS Corporation
  • Bausch+Strobel Maschinenfabrik
  • Bosch Rexroth AG
  • Brooks Automation (now Azenta)
  • Festo AG & Co. KG
  • Honeywell International Inc.
  • IMA Group
  • Korber Pharma
  • Marchesini Group
  • Mitsubishi Electric Corporation
  • Omron Corporation
  • Rockwell Automation, Inc.
  • Romaco Group
  • Schneider Electric
  • Siemens AG
  • Systec & Services GmbH
  • Yaskawa Electric Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Pharmaceutical Automation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Operational Efficiency and Error Reduction Propels Investment in Pharmaceutical Automation
    • Growth in Complex Biologics and Personalized Medicines Expands the Addressable Market for Adaptive Automation Solutions
    • Adoption of Robotics and Cobots in Fill-Finish and Packaging Lines Drives Productivity and Contamination Control
    • Real-Time Data Monitoring and Process Analytics Throw the Spotlight on Smart Manufacturing Systems
    • Integration of AI and Machine Learning Accelerates Predictive Maintenance and Quality Control Capabilities
    • Shift Toward Continuous Manufacturing Spurs Deployment of Fully Integrated Automation Platforms
    • Increased Focus on Data Integrity and Audit Readiness Drives Demand for 21 CFR Part 11-Compliant Systems
    • Workforce Shortages and Rising Labor Costs Propel Adoption of Automated Material Handling and Inspection Solutions
    • Pharma 4.0 Initiatives Strengthen Digital Transformation Roadmaps Across Manufacturing Facilities
    • Rising Adoption of MES and SCADA Systems Enables End-to-End Visibility and Traceability in Production
    • Growth in Aseptic Processing Facilities Throws the Spotlight on Precision Robotics and Closed-Loop Automation
    • Expansion of CDMO and Outsourced Production Services Sustains Demand for Scalable Automation Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pharmaceutical Automation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pharmaceutical Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pharmaceutical Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Pharmaceutical Automation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Solutions Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Solutions Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Solutions Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Semi-Automatic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Semi-Automatic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Semi-Automatic Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Fully Automatic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Fully Automatic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Fully Automatic Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Pharmaceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Biotech End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Biotech End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Biotech End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Pharmaceutical Automation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Pharmaceutical Automation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Pharmaceutical Automation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: France 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: France 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: UK 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Spain 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 116: Russia Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Russia Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Russia 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Automation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Pharmaceutical Automation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Pharmaceutical Automation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 146: Australia Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Australia Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Australia 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 155: India Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: India Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: India 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 158: India Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: India 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: India 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 164: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: South Korea Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: South Korea 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 173: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Asia-Pacific Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Rest of Asia-Pacific 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 182: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Automation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 183: Latin America Historic Review for Pharmaceutical Automation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Latin America 16-Year Perspective for Pharmaceutical Automation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 194: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Argentina Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Argentina 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Argentina 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 203: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Brazil Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Brazil 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 212: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Mexico Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Mexico 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 221: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of Latin America Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Rest of Latin America 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 230: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Automation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 231: Middle East Historic Review for Pharmaceutical Automation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Middle East 16-Year Perspective for Pharmaceutical Automation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 242: Iran Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Iran Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Iran 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Iran 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 251: Israel Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Israel Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Israel 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Israel 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 260: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Saudi Arabia Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Saudi Arabia 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Saudi Arabia 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 269: UAE Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: UAE Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: UAE 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: UAE 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 278: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Rest of Middle East Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Rest of Middle East 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Rest of Middle East 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Pharmaceutical Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 287: Africa Recent Past, Current & Future Analysis for Pharmaceutical Automation by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Africa Historic Review for Pharmaceutical Automation by Component - Solutions Component and Services Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: Africa 16-Year Perspective for Pharmaceutical Automation by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2014, 2025 & 2030
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Pharmaceutical Automation by Automation Mode - Semi-Automatic Systems and Fully Automatic Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: Africa 16-Year Perspective for Pharmaceutical Automation by Automation Mode - Percentage Breakdown of Value Sales for Semi-Automatic Systems and Fully Automatic Systems for the Years 2014, 2025 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Pharmaceutical Automation by End-Use - Pharmaceuticals End-Use and Biotech End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Pharmaceutical Automation by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use and Biotech End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제